Lixte Biotechnology logo

Lixte Biotechnology Share Price Today

(NASDAQ: LIXT)

Lixte Biotechnology share price is $1.2 & ₹104.48 as on 6 Mar 2025, 2.30 'hrs' IST

$1.2

-0.01

(-0.83%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lixte Biotechnology share price in Dollar and Rupees. Guide to invest in Lixte Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lixte Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Lixte Biotechnology share price movements

  • Today's Low: $1.16
    Today's High: $1.22

    Day's Volatility :4.92%

  • 52 Weeks Low: $1.16
    52 Weeks High: $4.40

    52 Weeks Volatility :73.64%

Lixte Biotechnology (LIXT) Returns

PeriodLixte Biotechnology Holdings IncIndex (Russel 2000)
3 Months
-39.39%
0.0%
6 Months
-41.46%
0.0%
1 Year
-50.41%
0.0%
3 Years
-91.18%
-11.6%

Lixte Biotechnology (LIXT) Key Statistics

in dollars & INR

Previous Close
$1.21
Open
$1.22
Today's High
$1.22
Today's Low
$1.16
Market Capitalization
$3.2M
Today's Volume
$20.3K
52 Week High
$4.4
52 Week Low
$1.16
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-127.21%

How to invest in Lixte Biotechnology Stock (LIXT) from India?

It is very easy for Indian residents to invest directly in Lixte Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lixte Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lixte Biotechnology or LIXT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lixte Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lixte Biotechnology shares which would translate to 0.726 fractional shares of Lixte Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lixte Biotechnology, in just a few clicks!

Returns in Lixte Biotechnology (LIXT) for Indian investors in Rupees

The Lixte Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lixte Biotechnology investment value today

Current value as on today

₹54,651

Returns

₹45,349

(-45.35%)

Returns from Lixte Biotechnology Stock

₹50,413 (-50.41%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Lixte Biotechnology (LIXT)

80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lixte Biotechnology Stock from India on INDmoney has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lixte Biotechnology

  • TIAA Trust National Association

    3.79%

  • HighTower Advisors, LLC

    3.70%

  • FNY Investment Advisers, LLC

    1.46%

  • Ethos Financial Group LLC

    0.92%

  • Geode Capital Management, LLC

    0.63%

  • Atlas Legacy Advisors, LLC

    0.47%

Analyst Recommendation on Lixte Biotechnology

Insights on Lixte Biotechnology Stock (Ticker Symbol: LIXT)

  • Price Movement

    In the last 7 days, LIXT stock has moved down by -14.3%
  • LIXT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 116.9%
  • LIXT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 142.7%

Lixte Biotechnology Technicals Summary

Sell

Neutral

Buy

Lixte Biotechnology is currently in a neutral trading position according to technical analysis indicators.

Lixte Biotechnology (LIXT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lixte Biotechnology Holdings Inc logo
-58.36%
-41.46%
-50.41%
-91.18%
-96.79%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lixte Biotechnology Holdings Inc logo
NA
NA
0.0
0.0
-1.27
-0.72
NA
-0.95
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lixte Biotechnology Holdings Inc logo
NA
$3.2M
-96.79%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Lixte Biotechnology

LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colon cancer. The company's Phase 1b portion of its advanced soft tissue sarcoma clinical trial seeks to determine appropriate dosing and toxicity for treating soft tissue sarcomas with combination of LB-100 and standard-of-care chemotherapy; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Organization
Lixte Biotechnology
Employees
3
CEO
Mr. Bastiaan van der Baan M.Sc.
Industry
Biotechnology

Management People of Lixte Biotechnology

NameTitle
Mr. Bastiaan van der Baan M.Sc.
President, CEO & Chairman of the Board of Directors
Mr. Robert Neal Weingarten
VP & CFO
Mr. Johannes Henricus Matthias Schellens M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in LIXT Stock from India :

What is Lixte Biotechnology share price today?

Lixte Biotechnology share price today stands at $1.20, Open: $1.22 ; Previous Close: $1.21 ; High: $1.22 ; Low: $1.16 ; 52 Week High: $4.40 ; 52 Week Low: $1.16.

The stock opens at $1.22, after a previous close of $1.21. The stock reached a daily high of $1.22 and a low of $1.16, with a 52-week high of $4.40 and a 52-week low of $1.16.

Can Indians buy Lixte Biotechnology shares?

Yes, Indians can invest in the Lixte Biotechnology (LIXT) from India.

With INDmoney, you can buy Lixte Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lixte Biotechnology at zero transaction cost.

How can I buy Lixte Biotechnology shares from India?

It is very easy to buy Lixte Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lixte Biotechnology (LIXT) be purchased?

Yes, you can buy fractional shares of Lixte Biotechnology with INDmoney app.

What are the documents required to start investing in Lixte Biotechnology stocks?

To start investing in Lixte Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lixte Biotechnology Stock (LIXT)?

Today’s highest price of Lixte Biotechnology (LIXT) is $1.22.

Today’s lowest price of Lixte Biotechnology (LIXT) is $1.16.

What is today's market capitalisation of Lixte Biotechnology?

Today's market capitalisation of Lixte Biotechnology LIXT is 3.2M

What is the 52 Week High and Low Range of Lixte Biotechnology Stock (LIXT)?

  • 52 Week High

    $4.40

  • 52 Week Low

    $1.16

What are the historical returns of Lixte Biotechnology (LIXT)?

  • 1 Month Returns

    -58.36%

  • 3 Months Returns

    -41.46%

  • 1 Year Returns

    -50.41%

  • 5 Years Returns

    -96.79%

Who is the Chief Executive Officer (CEO) of Lixte Biotechnology ?

Mr. Bastiaan van der Baan M.Sc. is the current Chief Executive Officer (CEO) of Lixte Biotechnology.